Tesamorelin: FDA-Approved GHRH Analog, Lipodystrophy & GH Research
What Is Tesamorelin? Tesamorelin (brand name Egrifta) is a synthetic analog of growth hormone-releasing hormone (GHRH) that has received FDA approval for the reduction of excess abdominal fat (lipodystrophy) in HIV-infected patients with lipohypertrophy.